ESC Congress 2026 Abstract · Oct 26, 2026
Smoking habit and changes of endothelial glycocalyx and arterial stiffness in AMI patients after one year follow up
By Thymis J, Gatourtzidou E, Georgiopoulos G et al.
Background: Smoking cessation constitutes a fundamental secondary prevention intervention after ST elevation Myocardial Infarction (STEMI). Purpose: We investigated at 12 months after STEMI the association between smoking status with mood disorder and their interrelation with arterial stiffness and integrity of endothelial glycocalyx. Methods: We included smokers hospitalized for STEMI. We also included a matched group (for age, sex, hypertension, diabetes, hyperlipidemia) of STEMI non-smokers as a control group. All smokers had attended the smoking cessation clinic after their discharge for their index event. We evaluated at baseline, at 6 and at 12 months: a) smoking status and nicotine dependence via Fagerström Test, b) levels of depressive symptoms via Zung Self-Rating Depression Scale, c) arterial stiffness via carotid-to-femoral pulse wave velocity (PWV), central systolic blood pressure (cSBP) and d) thickness of endothelial glycocalyx through measurement of perfused boundary region of the sublingual microvessels with diameter range 4-25 μm. Results: We totally included 190 STEMI patients, aged 59±8 years, 133/190 (70%) were males, of which 150 were active smokers and 40 non-smokers (control group). At 6-month follow-up, 91/150 (60,6%) smokers had quitted smoking and managed to abstain from smoking at 12-month follow-up. Out of 91 quitters, 70 (77%) quitted smoking on their own , 10 (11%) received Nicotine replacement therapy and 11 (12%) cytisinicline. Fageström score was reduced significantly during follow-up assessments (from 4.68±1.13 to 1.75±0.36 to 1.26±0.23 respectively, p<0.05), whereas Zung score remained unchanged (p>0.05). Baseline Fageström score was associated with baseline Zung score (r=0.218, p=0.036) and this association was not overt at follow-up. During 12-month follow-up, smoking AMI quitters and non smokers displayed a significant decrease of PBR4-25, PWV, cSBP compared to AMI patients who continued smoking (for PBR4-25: -5.65% and -6.57% vs -0.95% respectively, p<0.05;for PWV: -18.39% and -13.74% vs -3.41% respectively, p<0.05; for cSBP: -9.30% and -7.25% vs 11.92%, p<0.05). Among those who continued smoking those who further increasedFagerström score at 1 year showed greater increase of PWV (r=0.364, p=0.04) Conclusions: One year after the after the index event, STEMI smokers who quit smoking one showed a similar amelioration of arterial stiffness and integrity of endothelial glycocalyx to non smoker AMI patients while those who continued smoking showed no improvement in vascular functionTable
doi.org/10.1093/eurheartj/ehag785.4233Open accessInterventions